PK
TEVA icon

Pflug Koory’s Teva Pharmaceuticals TEVA Stock Holding History

Pflug Koory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$2K – 507
2021
Q1 		$2K Hold
200
– – ﹤0.01% 489
2020
Q4 		$2K Buy
+200
New +$1.92K ﹤0.01% 418
2020
Q1 		– Sell
-168
Closed -$2K – 423
2019
Q4 		$2K Hold
168
– – ﹤0.01% 400
2019
Q3 		$1K Hold
168
– – ﹤0.01% 406
2019
Q2 		$2K Sell
168
-500
-75% -$6.03K ﹤0.01% 395
2019
Q1 		$10K Hold
668
– – 0.01% 336
2018
Q4 		$10K Sell
668
-500
-43% -$10.3K 0.01% 319
2018
Q3 		$25K Sell
1,168
-100
-8% -$2.32K 0.02% 264
2018
Q2 		$31K Sell
1,268
-185
-13% -$3.77K 0.02% 247
2018
Q1 		$25K Hold
1,453
– – 0.02% 257
2017
Q4 		$28K Sell
1,453
-560
-28% -$8.42K 0.02% 246
2017
Q3 		$35K Buy
2,013
+300
+18% +$6.75K 0.03% 238
2017
Q2 		$57K Buy
1,713
+309
+22% +$9.56K 0.05% 207
2017
Q1 		$45K Buy
1,404
+350
+33% +$11.9K 0.04% 212
2016
Q4 		$38 Buy
+1,054
New +$42.1K 0.03% 214

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Pflug Koory's TEVA Position: Q2 2021 in Review

Pflug Koory sold out of Teva Pharmaceuticals (TEVA) in Q2 2021, closing a stake of 200 shares — an estimated $2K sold.

Pflug Koory first reported a position in TEVA in Q4 2016 and held it in 15 quarters. The position peaked at $57K in Q2 2017. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Pflug Koory reported no remaining Teva Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pflug Koory sold 200 Teva Pharmaceuticals shares in Q2 2021, an estimated $2K.
  • Pflug Koory first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 15 quarters.
  • Pflug Koory's Teva Pharmaceuticals position peaked at $57K in Q2 2017.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2021.

Based on Pflug Koory's 13F filing for Q2 2021, filed 14 Jul 2021.